Interestingly, chemotherapy treatments (DPC for TNBC and crizotinib and topotecan for PR+BC) strongly affect-ed OGG1 levels, causing statistically significant decrea-ses in the levels of this DNA repair protein (Fig. 6B). Here, OGG1 is linked to breast cancer.